262 related articles for article (PubMed ID: 22731805)
1. Challenges and opportunities in the targeting of fibroblast growth factor receptors in breast cancer.
Jain VK; Turner NC
Breast Cancer Res; 2012 Jun; 14(3):208. PubMed ID: 22731805
[TBL] [Abstract][Full Text] [Related]
2. Selective over-expression of fibroblast growth factor receptors 1 and 4 in clinical prostate cancer.
Sahadevan K; Darby S; Leung HY; Mathers ME; Robson CN; Gnanapragasam VJ
J Pathol; 2007 Sep; 213(1):82-90. PubMed ID: 17607666
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factor receptors in breast cancer.
Wang S; Ding Z
Tumour Biol; 2017 May; 39(5):1010428317698370. PubMed ID: 28459213
[TBL] [Abstract][Full Text] [Related]
4. Targeting FGFR with dovitinib (TKI258): preclinical and clinical data in breast cancer.
André F; Bachelot T; Campone M; Dalenc F; Perez-Garcia JM; Hurvitz SA; Turner N; Rugo H; Smith JW; Deudon S; Shi M; Zhang Y; Kay A; Porta DG; Yovine A; Baselga J
Clin Cancer Res; 2013 Jul; 19(13):3693-702. PubMed ID: 23658459
[TBL] [Abstract][Full Text] [Related]
5. FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium.
Agarwal D; Pineda S; Michailidou K; Herranz J; Pita G; Moreno LT; Alonso MR; Dennis J; Wang Q; Bolla MK; Meyer KB; Menéndez-Rodríguez P; Hardisson D; Mendiola M; González-Neira A; Lindblom A; Margolin S; Swerdlow A; Ashworth A; Orr N; Jones M; Matsuo K; Ito H; Iwata H; Kondo N; ; ; Hartman M; Hui M; Lim WY; Iau PT; Sawyer E; Tomlinson I; Kerin M; Miller N; Kang D; Choi J-; Park SK; Noh D-; Hopper JL; Schmidt DF; Makalic E; Southey MC; Teo SH; Yip CH; Sivanandan K; Tay W-; Brauch H; Brüning T; Hamann U; ; Dunning AM; Shah M; Andrulis IL; Knight JA; Glendon G; Tchatchou S; Schmidt MK; Broeks A; Rosenberg EH; van't Veer LJ; Fasching PA; Renner SP; Ekici AB; Beckmann MW; Shen C-; Hsiung C-; Yu J-; Hou M-; Blot W; Cai Q; Wu AH; Tseng C-; Van Den Berg D; Stram DO; Cox A; Brock IW; Reed MW; Muir K; Lophatananon A; Stewart-Brown S; Siriwanarangsan P; Zheng W; Deming-Halverson S; Shrubsole MJ; Long J; Shu X-; Lu W; Gao Y-; Zhang B; Radice P; Peterlongo P; Manoukian S; Mariette F; Sangrajrang S; McKay J; Couch FJ; Toland AE; ; Yannoukakos D; Fletcher O; Johnson N; dos Santos Silva I; Peto J; Marme F; Burwinkel B; Guénel P; Truong T; Sanchez M; Mulot C; Bojesen SE; Nordestgaard BG; Flyer H; Brenner H; Dieffenbach AK; Arndt V; Stegmaier C; Mannermaa A; Kataja V; Kosma V-; Hartikainen JM; Lambrechts D; Yesilyurt BT; Floris G; Leunen K; Chang-Claude J; Rudolph A; Seibold P; Flesch-Janys D; Wang X; Olson JE; Vachon C; Purrington K; Giles GG; Severi G; Baglietto L; Haiman CA; Henderson BE; Schumacher F; Marchand LL; Simard J; Dumont M; Goldberg MS; Labréche F; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Grip M; Devilee P; Tollenaar RA; Seynaeve C; García-Closas M; Chanock SJ; Lissowska J; Figueroa JD; Czene K; Eriksson M; Humphreys K; Darabi H; Hooning MJ; Kriege M; Collée JM; Tilanus-Linthorst M; Li J; Jakubowska A; Lubinski J; Jaworska-Bieniek K; Durda K; Nevanlinna H; Muranen TA; Aittomäki K; Blomqvist C; Bogdanova N; Dörk T; Hall P; Chenevix-Trench G; Easton DF; Pharroah PD; Arias-Perez JI; Zamora P; Benítez J; Milne RL
Br J Cancer; 2014 Feb; 110(4):1088-100. PubMed ID: 24548884
[TBL] [Abstract][Full Text] [Related]
6. Different abilities of the four FGFRs to mediate FGF-1 translocation are linked to differences in the receptor C-terminal tail.
Sørensen V; Wiedlocha A; Haugsten EM; Khnykin D; Wesche J; Olsnes S
J Cell Sci; 2006 Oct; 119(Pt 20):4332-41. PubMed ID: 17003104
[TBL] [Abstract][Full Text] [Related]
7. Genomic aberrations in the FGFR pathway: opportunities for targeted therapies in solid tumors.
Dienstmann R; Rodon J; Prat A; Perez-Garcia J; Adamo B; Felip E; Cortes J; Iafrate AJ; Nuciforo P; Tabernero J
Ann Oncol; 2014 Mar; 25(3):552-563. PubMed ID: 24265351
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Role of FGFR Alterations and FGFR mRNA Expression in Metastatic Urothelial Cancer Undergoing Checkpoint Inhibitor Therapy.
Tully KH; Jütte H; Wirtz RM; Jarczyk J; Santiago-Walker A; Zengerling F; Breyer J; Sikic D; Kriegmair MC; von Hardenberg J; Wullich B; Taubert H; Weyerer V; Stoehr R; Bolenz C; Burger M; Porubsky S; Hartmann A; Roghmann F; Erben P; Eckstein M
Urology; 2021 Nov; 157():93-101. PubMed ID: 34153367
[TBL] [Abstract][Full Text] [Related]
9. Futibatinib Is a Novel Irreversible FGFR 1-4 Inhibitor That Shows Selective Antitumor Activity against FGFR-Deregulated Tumors.
Sootome H; Fujita H; Ito K; Ochiiwa H; Fujioka Y; Ito K; Miura A; Sagara T; Ito S; Ohsawa H; Otsuki S; Funabashi K; Yashiro M; Matsuo K; Yonekura K; Hirai H
Cancer Res; 2020 Nov; 80(22):4986-4997. PubMed ID: 32973082
[TBL] [Abstract][Full Text] [Related]
10. Rationale for targeting fibroblast growth factor receptor signaling in breast cancer.
André F; Cortés J
Breast Cancer Res Treat; 2015 Feb; 150(1):1-8. PubMed ID: 25677745
[TBL] [Abstract][Full Text] [Related]
11. Exploring mechanisms of FGF signalling through the lens of structural biology.
Goetz R; Mohammadi M
Nat Rev Mol Cell Biol; 2013 Mar; 14(3):166-80. PubMed ID: 23403721
[TBL] [Abstract][Full Text] [Related]
12. Impact of fibroblast growth factor receptor 1 (FGFR1) amplification on the prognosis of breast cancer patients.
Erber R; Rübner M; Davenport S; Hauke S; Beckmann MW; Hartmann A; Häberle L; Gass P; Press MF; Fasching PA
Breast Cancer Res Treat; 2020 Nov; 184(2):311-324. PubMed ID: 32852708
[TBL] [Abstract][Full Text] [Related]
13. Differential roles of fibroblast growth factor receptors (FGFR) 1, 2 and 3 in the regulation of S115 breast cancer cell growth.
Tarkkonen KM; Nilsson EM; Kähkönen TE; Dey JH; Heikkilä JE; Tuomela JM; Liu Q; Hynes NE; Härkönen PL
PLoS One; 2012; 7(11):e49970. PubMed ID: 23185502
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast growth factor receptor 4 predicts failure on tamoxifen therapy in patients with recurrent breast cancer.
Meijer D; Sieuwerts AM; Look MP; van Agthoven T; Foekens JA; Dorssers LC
Endocr Relat Cancer; 2008 Mar; 15(1):101-11. PubMed ID: 18310279
[TBL] [Abstract][Full Text] [Related]
15. Amplification of FRS2 and activation of FGFR/FRS2 signaling pathway in high-grade liposarcoma.
Zhang K; Chu K; Wu X; Gao H; Wang J; Yuan YC; Loera S; Ho K; Wang Y; Chow W; Un F; Chu P; Yen Y
Cancer Res; 2013 Feb; 73(4):1298-307. PubMed ID: 23393200
[TBL] [Abstract][Full Text] [Related]
16. FGFR1-4 RNA-Based Gene Alteration and Expression Analysis in Squamous Non-Small Cell Lung Cancer.
Moes-Sosnowska J; Skupinska M; Lechowicz U; Szczepulska-Wojcik E; Skronska P; Rozy A; Stepniewska A; Langfort R; Rudzinski P; Orlowski T; Popiel D; Stanczak A; Wieczorek M; Chorostowska-Wynimko J
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142417
[TBL] [Abstract][Full Text] [Related]
17. FGFR gene alterations in lung squamous cell carcinoma are potential targets for the multikinase inhibitor nintedanib.
Hibi M; Kaneda H; Tanizaki J; Sakai K; Togashi Y; Terashima M; De Velasco MA; Fujita Y; Banno E; Nakamura Y; Takeda M; Ito A; Mitsudomi T; Nakagawa K; Okamoto I; Nishio K
Cancer Sci; 2016 Nov; 107(11):1667-1676. PubMed ID: 27581340
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of FGFR targeting in breast cancer through interrogation of patient-derived models.
Chew NJ; Lim Kam Sian TCC; Nguyen EV; Shin SY; Yang J; Hui MN; Deng N; McLean CA; Welm AL; Lim E; Gregory P; Nottle T; Lang T; Vereker M; Richardson G; Kerr G; Micati D; Jardé T; Abud HE; Lee RS; Swarbrick A; Daly RJ
Breast Cancer Res; 2021 Aug; 23(1):82. PubMed ID: 34344433
[TBL] [Abstract][Full Text] [Related]
19. Differential distribution of fibroblast growth factor receptors (FGFRs) on foveal cones: FGFR-4 is an early marker of cone photoreceptors.
Cornish EE; Natoli RC; Hendrickson A; Provis JM
Mol Vis; 2004 Jan; 10():1-14. PubMed ID: 14737068
[TBL] [Abstract][Full Text] [Related]
20. Association of FGFR3 and FGFR4 gene polymorphisms with breast cancer in Chinese women of Heilongjiang province.
Jiang Y; Sun S; Wei W; Ren Y; Liu J; Pang D
Oncotarget; 2015 Oct; 6(32):34023-9. PubMed ID: 26431494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
